Integrated Core Strategies (US) LLC 13D and 13G filings for iTeos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-09 4:26 pm Sale | 2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | Integrated Core Strategies (US) LLC | 967,402 2.700% | -1,123,431 (-53.73%) | Filing |
| 2023-10-24 4:12 pm Purchase | 2023-10-17 | 13G | iTeos Therapeutics, Inc. ITOS | Integrated Core Strategies (US) LLC | 2,090,833 5.800% | 2,090,833 (New Position) | Filing |